David W. Andrews

Co-Founder & Chief Medical Officer

Philadelphia, United States

David W. Andrews, MD, is co-founder and Chief Medical Officer of Imvax and has led development of its lead candidate IGV-001 for glioblastoma over two decades of research at Thomas Jefferson University. He is the Anthony Alfred Chiurco, MD Professor of Neurological Surgery and Vice Chair of Clinical Services at the Vickie and Jack Farber Institute for Neuroscience, and served as Imvax's interim CEO before John Furey's appointment.

Expertise

• Neuro-Oncology
• Immunotherapy
• Clinical Research